Endometrial Serous Adenocarcinoma — Trials

Endometrial Serous Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 7
Ph III recruiting: 2
Growth YoY: —
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06792552	A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors	recruiting	Phase 1	738	NextCure, Inc.INDUSTRY	2	Aug 17, 2026	clinicaltrials
NCT06476808	A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.	recruiting	Phase 1	240	Bristol-Myers SquibbINDUSTRY	5	Jul 20, 2026	clinicaltrials